Senthilkumar Balakrishnan

Dr. Senthilkumar Balakrishnan

Tamil Nadu State Council for Science and Technology, Chennai, India
orcid

Research Focus & Metrics

Academic Career Length

22Years (2005-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 December 2019 in JAMA Oncology
Verified
Journal Article
Open access
PDF file
GCGlobal Burden of Disease Cancer Collaboration
Global Burden of Disease Cancer Collaboration
CFChristina Fitzmaurice
Christina Fitzmaurice
DADegu Abate
Degu Abate
NANaghmeh Abbasi
Naghmeh Abbasi
HAHedayat Abbastabar
Hedayat Abbastabar
CMChristopher J. L. Murray
Christopher J. L. Murray
Cancer is now widely recognized as a global problem that unfortunately lacks a global solution. The latest United Nations high-level meeting on noncommunicable diseases (NCDs) exemplified this conundrum.1 Despite global commitment to reducing the risk of and disability from NCDs, including cancer, implementation of known solutions is inadequate to reach the 2011 Political Declaration on the Prevention and Control of Noncommunicable Diseases2,3 (25% reduction in premature mortality from NCDs by 2025) and the third Sustainable Development Goal (by 2030 reduce by one-third premature mortality from NCDs through prevention and treatment, and promote mental health and well-being).4 To reduce cancer burden, identifying the scope of the problem and mapping out implementation of solutions is best done in National Cancer Control Plans (NCCPs). However, a recent review showed that only 29% of low-income countries had a NCCP, and even if NCCPs existed, cost, financing, monitoring, and expansion of information systems was often inadequate. Many highly effective prevention and treatment strategies exist for cancer. However, they are often very specific (eg, vaccination for human papillomavirus and hepatitis B virus for prevention of cervical and liver cancer, or tyrosine kinase inhibitors for cancers with targetable mutations). Effective NCCPs therefore require detailed knowledge about the local burden of cancer and associated risk factors. We herein present results from the Global Burden of Disease (GBD) 2017 study describing cancer incidence, mortality, years of life lost (YLLs), years lived with disability (YLDs), and disability-adjusted life-years (DALYs) for 195 countries from 1990 through 2017, which can inform cancer control through policy, resource allocation, and health system planning.

1 September 2020 in The Lancet Global Health
Verified
Journal Article
Open access
ADAniruddha Deshpande
Aniruddha Deshpande
MMMolly K Miller-Petrie
Molly K Miller-Petrie
PLPaulina A Lindstedt
Paulina A Lindstedt
MBMathew M Baumann
Mathew M Baumann
KJKimberly B Johnson
Kimberly B Johnson
RRRobert C Reiner
Robert C Reiner
Universal access to safe drinking water and sanitation facilities is an essential human right, recognised in the Sustainable Development Goals as crucial for preventing disease and improving human wellbeing. Comprehensive, high-resolution estimates are important to inform progress towards achieving this goal. We aimed to produce high-resolution geospatial estimates of access to drinking water and sanitation facilities. We used a Bayesian geostatistical model and data from 600 sources across more than 88 low-income and middle-income countries (LMICs) to estimate access to drinking water and sanitation facilities on continuous continent-wide surfaces from 2000 to 2017, and aggregated results to policy-relevant administrative units. We estimated mutually exclusive and collectively exhaustive subcategories of facilities for drinking water (piped water on or off premises, other improved facilities, unimproved, and surface water) and sanitation facilities (septic or sewer sanitation, other improved, unimproved, and open defecation) with use of ordinal regression. We also estimated the number of diarrhoeal deaths in children younger than 5 years attributed to unsafe facilities and estimated deaths that were averted by increased access to safe facilities in 2017, and analysed geographical inequality in access within LMICs. Across LMICs, access to both piped water and improved water overall increased between 2000 and 2017, with progress varying spatially. For piped water, the safest water facility type, access increased from 40·0% (95% uncertainty interval [UI] 39·4-40·7) to 50·3% (50·0-50·5), but was lowest in sub-Saharan Africa, where access to piped water was mostly concentrated in urban centres. Access to both sewer or septic sanitation and improved sanitation overall also increased across all LMICs during the study period. For sewer or septic sanitation, access was 46·3% (95% UI 46·1-46·5) in 2017, compared with 28·7% (28·5-29·0) in 2000. Although some units improved access to the safest drinking water or sanitation facilities since 2000, a large absolute number of people continued to not have access in several units with high access to such facilities (>80%) in 2017. More than 253 000 people did not have access to sewer or septic sanitation facilities in the city of Harare, Zimbabwe, despite 88·6% (95% UI 87·2-89·7) access overall. Many units were able to transition from the least safe facilities in 2000 to safe facilities by 2017; for units in which populations primarily practised open defecation in 2000, 686 (95% UI 664-711) of the 1830 (1797-1863) units transitioned to the use of improved sanitation. Geographical disparities in access to improved water across units decreased in 76·1% (95% UI 71·6-80·7) of countries from 2000 to 2017, and in 53·9% (50·6-59·6) of countries for access to improved sanitation, but remained evident subnationally in most countries in 2017. Our estimates, combined with geospatial trends in diarrhoeal burden, identify where efforts to increase access to safe drinking water and sanitation facilities are most needed. By highlighting areas with successful approaches or in need of targeted interventions, our estimates can enable precision public health to effectively progress towards universal access to safe water and sanitation. Bill & Melinda Gates Foundation.

1 January 2017 in Journal of Radiation Research and Applied Sciences
Verified
Journal Article
Open access
KSKandasamy Selvam
Kandasamy Selvam
CSChinnappan Sudhakar
Chinnappan Sudhakar
MGMuthusamy Govarthanan
Muthusamy Govarthanan
PTPeriasamy Thiyagarajan
Periasamy Thiyagarajan
ASArumugam Sengottaiyan
Arumugam Sengottaiyan
TSThangasamy Selvankumar
Thangasamy Selvankumar
The present study reports an eco-friendly, rapid and easy method for synthesis of silver nanoparticles (AgNPs) using Tinospora cordifolia as a reducing and capping agent. The different factor such as silver nitrate (AgNO3) concentration, fresh weight of T. cordifolia leaf, incubation time, and pH affecting silver reduction was investigated using Response surface methodology based Box–Behnken design (BBD). The optimum conditions were AgNO3 (1.25 mM), incubation time (15 h), Temperature (45 °C) and pH (4.5). T. cordifolia leaf extract can reduces silver ions into AgNPs within 30 min after heating the reaction mixture (60 °C) as indicated by the developed reddish brown color. The UV-Vis spectrum of AgNPs revealed a characteristic surface plasmon resonance (SPR) peak at 430 nm. AgNPs were characterized X-ray diffraction (XRD) revealed their crystalline nature and their average size of nanoparticles was 30 nm as determined by using Scherrer's equation. Fourier transform infrared (FTIR) spectroscopy affirmed the role of T. cordifolia leaf extract as a reducing and capping agent of silver ions. Scanning electron microscope-energy dispersive X-ray spectroscopy (SEM-EDS) showed spherical shaped and confirming presence of elemental silver. The synthesized AgNPs was found higher antioxidant activity than plant extract by dot plot assay. In addition, antibacterial activity against Staphylococcus sp. (NCBI-Accession: KC688883.1) and Klebsiella sp. (NCBI-Accession: KF649832.1), showed maximum zone of inhibition of 13 mm and 12.3 mm, respectively, at 10 μg/mL of AgNPs. From the results it is suggested that the synthesized AgNPs showed higher antioxidant and antibacterial activity than the plant extract, thus signification of the present study is the production of biomedical products

1 February 2020 in Optik
Verified
Journal Article
Closed access
SKSukumar Kayalvizhi
Sukumar Kayalvizhi
ASArumugam Sengottaiyan
Arumugam Sengottaiyan
Selvankumar ThangaswamySelvankumar Thangaswamy
Selvankumar Thangaswamy
SBSenthilkumar Balakrishnan
Senthilkumar Balakrishnan
CSChinnappan Sudhakar
Chinnappan Sudhakar
KSKandasamy Selvam
Kandasamy Selvam

1 February 2016 in Therapeutics and Clinical Risk Management
Verified
Journal Article
Open access
PDF file
SBSenthilkumar Balakrishnan
Senthilkumar Balakrishnan
BDBehailu Derese
Behailu Derese
HKHaji Kedir
Haji Kedir
ZTZelalem Teklemariam
Zelalem Teklemariam
FWFitsum Weldegebreal
Fitsum Weldegebreal
Purpose: The aim of this study was to determine the bacterial profile of urinary tract infection (UTI) and antimicrobial susceptibility pattern among pregnant women attending at antenatal clinic in Dil Chora Referral Hospital, Dire Dawa, Eastern Ethiopia. Patients and methods: An institutional-based cross-sectional study was conducted from February 18, 2015 to March 25, 2015. Clean-catch midstream urine specimens were collected from 186 pregnant women using sterile containers. Then, culture and antimicrobial susceptibility tests were performed by standard disk diffusion method. Patient information was obtained using pretested structured questionnaire. Data were entered and cleaned using EpiData Version 3 and then exported to Statistical Package for Social Science (Version 16) for further analysis. Results: The prevalence of significant bacteriuria was 14%. Gram-negative bacteria were more prevalent (73%). Escherichia coli (34.6%), coagulase-negative staphylococci (19.2%), Pseudomonas aeruginosa (15.4%), and Klebsiella spp. (11.5%) were common bacterial isolates, where most of them were resistant against ampicillin, amoxicillin, tetracycline, trimethoprim–sulfamethoxazole, and chloramphenicol. Multidrug resistance (resistance in ≥2 drugs) was seen in 100% of the isolated bacteria. A majority of the bacterial isolates were sensitive to ciprofloxacin, ceftriaxone, erythromycin, and gentamicin. Conclusion: This study found a number of bacterial isolates with very high resistance to the commonly prescribed drugs from pregnant women with and without symptoms of UTI. Therefore, the early routine detection of causative agents of UTI and determining their drug susceptibility pattern are important for pregnant women to avoid complications in mother and fetus. Ciprofloxacin, ceftriaxone, gentamicin, and erythromycin can be used with great care for the empirical treatment of UTI.

16 August 2020 in Bioprocess and Biosystems Engineering
Verified
Journal Article
Closed access
PDF file
MGMani Gopu
Mani Gopu
Kumar PonnuchamyKumar Ponnuchamy
Kumar Ponnuchamy
TSThangasamy Selvankumar
Thangasamy Selvankumar
SBSenthilkumar Balakrishnan
Senthilkumar Balakrishnan
CSChinnappan Sudhakar
Chinnappan Sudhakar
KSKandasamy Selvam
Kandasamy Selvam